Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Infiltration”

398 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 398 results

Testing effectiveness (Phase 2)Study completedNCT00566098
What this trial is testing

Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 26
Not applicableStudy completedNCT05610592
What this trial is testing

Tumor Budding in Patients With Colorectal Cancer Under Different MMR Status

Who this might be right for
Tumor BuddingRectal Cancer
Sun Yat-sen University 480
Testing effectiveness (Phase 2)Active Not RecruitingNCT00295893
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 121
Very early researchLooking for participantsNCT07349160
What this trial is testing

Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Testing effectiveness (Phase 2)Looking for participantsNCT07288203
What this trial is testing

Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Melanoma

Who this might be right for
Melanoma (Skin Cancer)Unresectable MelanomaMetastatic Melanoma
Iovance Biotherapeutics, Inc. 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT05270824
What this trial is testing

Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma

Who this might be right for
Advanced Gastric CarcinomaCD8+ Tumor Infiltrating LymphocytesNeoadjuvant Immunotherapy
Fujian Medical University 120
Not applicableEnded earlyNCT01062919
What this trial is testing

Local Anesthetic Wound Infusion and Functional Recovery After Colon Surgery

Who this might be right for
Colon CancerInflammatory Bowel DiseasesDiverticulitis
Franco Carli 10
Early research (Phase 1)Looking for participantsNCT06375187
What this trial is testing

GC203 TIL in Advanced Malignant Solid Tumors

Who this might be right for
Solid TumorGynecologic CancerBreast Cancer+2 more
Shanghai Juncell Therapeutics 18
Testing effectiveness (Phase 2)UnknownNCT00610389
What this trial is testing

Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors

Who this might be right for
Renal Cell CarcinomaMelanomaCarcinoma, Hepatocellular
Clinica Universidad de Navarra, Universidad de Navarra 27
Early research (Phase 1)Active Not RecruitingNCT05902520
What this trial is testing

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Who this might be right for
HNSCCMelanomaGynecologic Cancer+3 more
AgonOx, Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06059690
What this trial is testing

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

Who this might be right for
Glioblastoma MultiformeGlycolytic IndexEpidermal Growth Factor Receptor
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT02383498
What this trial is testing

QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma

Who this might be right for
Chordoma
NantCell, Inc. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05729399
What this trial is testing

Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors

Who this might be right for
Solid Tumor
Grit Biotechnology 42
Testing effectiveness (Phase 2)Looking for participantsNCT04260256
What this trial is testing

A Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Solid Tumors

Who this might be right for
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
CellSight Technologies, Inc. 40
Not applicableStudy completedNCT01328873
What this trial is testing

FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates

Who this might be right for
Pulmonary Infiltrate New
Northside Hospital, Inc. 49
Testing effectiveness (Phase 2)Looking for participantsNCT07330037
What this trial is testing

TALENT Study: Phase II Trial of Adjuvant L-TIL Plus Tislelizumab in Resectable NSCLC Without pCR After Neoadjuvant Chemoimmunotherapy

Who this might be right for
NSCLC
Tianjin Medical University Cancer Institute and Hospital 41
Early research (Phase 1)Active Not RecruitingNCT05681780
What this trial is testing

Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC

Who this might be right for
Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerRecurrent Non Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute 13
Testing effectiveness (Phase 2)Study completedNCT01319565
What this trial is testing

Prospective Randomized Study of Cell Transfer Therapy for Metastatic Melanoma Using Tumor Infiltrating Lymphocytes Plus IL-2 Following Non-Myeloablative Lymphocyte Depleting Chemo Regimen Alone or in Conjunction With 12Gy Total Body Irradiation (TBI...

Who this might be right for
Metastatic MelanomaSkin Cancer
National Cancer Institute (NCI) 102
Not applicableNot Yet RecruitingNCT06827639
What this trial is testing

In-depth Characterization of Circulating and Infiltrating Immune Subsets and Tumor Cells in Cancer Patients

Who this might be right for
Head and Neck CancerUrologic CancerLung Cancer+2 more
Assistance Publique Hopitaux De Marseille 640
Testing effectiveness (Phase 2)Ended earlyNCT05050006
What this trial is testing

ITIL-168 in Advanced Melanoma

Who this might be right for
Advanced Cutaneous Melanoma
Instil Bio 29
Load More Results